Arcturus Therapeutics Holdings ARCT
NASDAQ ARCT
$13.70 -0.76 (-5.26%)
At close: Sep 29, 2026 · 4:00 PM EDT

Arcturus Therapeutics Holdings (ARCT) Share-based Compensation (2018 - 2026)

Updated

Arcturus Therapeutics Holdings (ARCT) reported Share-based Compensation of $4.23 million for Q2 2026, down 31.8% from $6.2 million a year earlier and down 2.2% from the prior quarter.

Analysis

Arcturus Therapeutics Holdings (ARCT) Share-based Compensation (2018 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Arcturus Therapeutics Holdings' Share-based Compensation came in at $21.1 million, down 32.7% year-over-year; for FY2025, it was $25.41 million, down 33.1% from FY2024.

  • Share-based Compensation has a five-year compound annual growth rate of 30.3% (FY2020 to FY2025).
  • By year, Share-based Compensation came in at $37.99 million in FY2024 (+9.6%), $34.65 million in FY2023 (+13.2%), $30.61 million in FY2022 (+5.9%) and $28.92 million in FY2021 (+327.5%).
  • The Q2 2026 figure ranks as the lowest quarterly Share-based Compensation since Q4 2020.
  • Year over year, Share-based Compensation has now declined in each of the last six quarters, with an average decline of 24.3% over the last eight quarters.
  • The high point for year-over-year Share-based Compensation in five years was Q3 2021 (growth of 245.6%); the low point was Q3 2025 (a decline of 39.7%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $4.33 million (Q1 2026), $6.82 million (Q4 2025) and $5.73 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 458.00 Mn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 166.00 Mn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 298.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 165.00 Mn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 231.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 249.00 Mn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 170.20 Mn
10 Arcturus Therapeutics Holdings 411.00 Mn -403.13 Mn - 4.23 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.23 Mn
Mar 31, 2026 4.33 Mn
Dec 31, 2025 6.82 Mn
Sep 30, 2025 5.73 Mn
Jun 30, 2025 6.20 Mn
Mar 31, 2025 6.66 Mn
Dec 31, 2024 8.98 Mn
Sep 30, 2024 9.49 Mn
Jun 30, 2024 9.42 Mn
Mar 31, 2024 10.09 Mn
Dec 31, 2023 8.82 Mn
Sep 30, 2023 9.27 Mn
Jun 30, 2023 8.38 Mn
Mar 31, 2023 8.18 Mn
Dec 31, 2022 6.53 Mn
Sep 30, 2022 9.44 Mn
Jun 30, 2022 7.27 Mn
Mar 31, 2022 7.37 Mn
Dec 31, 2021 7.52 Mn
Sep 30, 2021 6.87 Mn
API Access

Arcturus Therapeutics Holdings Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=ARCT&period=max&api_key=YOUR_API_KEY